COMP <GO>
STIM vs PDEX // ALTMAN Z-SCORE & DEBT/EQUITY
Neuronetics Inc. (NASDAQ) VS. Pro-Dex Inc. (NASDAQ) • 15-METRIC TALLY: STIM 3
— PDEX 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PDEX
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
balance-sheet
0.20
LAST: $61.60 (-2.52%) • MKT CAP: $199.2M
balance-sheet
9.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STIM VS. PDEX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STIM | PDEX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.50% | 29.30% | +19.20 | STIM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 23.20% | -58.20 | PDEX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.25% | -1.47% | -9.78 | PDEX | /fcf-yield <GO> |
| Operating Margin | -21.10% | 16.10% | -37.20 | PDEX | /operating-margins <GO> |
| Net Profit Margin | -26.10% | 13.50% | -39.60 | PDEX | /net-margins <GO> |
| Revenue Growth (YoY) | 99.20% | 23.70% | +75.50 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | 9.08 | -8.88 | PDEX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.9 | 47.7 | +8.20 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $181.3M | $199.2M | -$17.8M | PDEX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STIM REV | PDEX REV | STIM GROSS % | PDEX GROSS % | STIM FCF | PDEX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $149.2M | $66.6M | 48.5% | 29.3% | -$20.4M | -$2.9M |
| FY 2024 | $74.9M | $53.8M | 72.3% | 27.0% | -$31.0M | $6.2M |
| FY 2023 | $71.3M | $46.1M | — | — | -$32.0M | $5.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STIM // BETA —
PDEX // BETA —